University of Wollongong

Research Online
University of Wollongong Thesis Collection
1954-2016

University of Wollongong Thesis Collections

2010

Optically stimulated luminescence (OSL) and its applications in radiation
therapy dosimetry
Bin Hu
University of Wollongong
Follow this and additional works at: https://ro.uow.edu.au/theses
University of Wollongong
Copyright Warning
You may print or download ONE copy of this document for the purpose of your own research or study. The University
does not authorise you to copy, communicate or otherwise make available electronically to any other person any
copyright material contained on this site.
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised,
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court
may impose penalties and award damages in relation to offences and infringements relating to copyright material.
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the
conversion of material into digital or electronic form.
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily
represent the views of the University of Wollongong.

Recommended Citation
Hu, Bin, Optically stimulated luminescence (OSL) and its applications in radiation therapy dosimetry,
Doctor of Philosophy thesis, University of Wollongong. School of Engineering Physics, University of
Wollongong, 2010. https://ro.uow.edu.au/theses/3181

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

OPTICALLY STIMULATED LUMINESCENCE (OSL)
AND ITS APPLICATIONS IN
RADIATION THERAPY DOSIMETRY

A thesis submitted in fulfilment of the requirements for the award of the degree
DOCTOR OF PHILOSOPHY
FROM THE
UNIVERSITY OF WOLLONGONG

BIN HU
ENGINEERING PHYSICS
2010

CERTIFICATION
I, Bin Hu, declare that this thesis, submitted in partial fulfilment of the
requirements for an award of Doctor of Philosophy in the Department of
Biological Sciences, University of Wollongong, is wholly my own work unless
otherwise referenced or acknowledged. The document has not been submitted
for qualifications at any other academic institution.

Bin Hu
18 October 2010

ACKNOWLEDGEMENTS
I would like to express the deepest appreciation to Professor Yang Wang, for
promoting my research project and supporting the experimental work. I would also like
to give my greatest thanks to Professor William Zealey, for his valuable advice and
guidance. They have provided strong support; their supervision and leadership helped
me tremendously.

My thanks also to all the staff of the Radiation Oncology Associated (ROA) at St.
Vincent’s Private, Sydney, for providing me the opportunity to undertake this research
project and to complete my thesis.

I would like to acknowledge a scholarship from the School of Engineering Physics,
University of Wollongong, Australia.

I give my grateful thanks to my parents, my dad, Yimin Hu, for offering his knowledge
for phantom design, thesis review, and for helping me accomplish this project; my
mother, Xilan Han, for taking care of my son. Without their support and their constant
love I could not have started or completed this project.

I give a special thank to one who doesn’t want to be mentioned, but he knows who he
is and what he did for me.

Abstract
Optically stimulated luminescence (OSL) was studied using a commercial OSL
dosimetry system developed by Landauer (Landauer Inc.,USA) to analyse the
possibility of using OSL dosimetry for external beam radiotherapy planning checks and
in-vivo dosimetry. Experiments were performed to determine signal sensitivity, dose
response range, beam type and energy dependency, reproducibility and linearity.
Optical annealing processes to test OSL material reusability were also studied. OSL
clinical usability was assessed by verifying IMRT dose distributions in a phantom and
measuring exit doses for in-vivo dosimetry.
Experimental results show that OSL dosimetry provides a wide dose response range
as well as good linearity and reproducibility for doses up to 600cGy, and up to 800cGy
shows a 2.0% maximum deviation from linearity. The standard deviation in the
response of screened dosimeters was 2.0%. As this needs to be taken into account
when OSLDs are used clinically, multiple readings of each irradiated OSLD are
recommended. OSLDs can be reused when an optical annealing process is applied,
which can restore the OSLD to its original state. After optical annealing using
incandescent light, the readout intensity decreased by approximately 98% in the first
30 minutes, decreasing further after repeated optical annealing according to the power
law, I  t 1.3 , where I is the light intensity.
Quantitative comparisons were made between treatment planning system (TPS)
calculated dose and OSL measurement points dose using a custom-designed
spherical phantom. Three clinical IMRT cases were used: Nasopharynx, Prostate and
Lung. Although quantitative comparisons are highly dependent on the calibration
accuracy and dose range of OSLDs, experimental results showed that the OSL dose is
within 3% of the TPS calculated dose with careful calibration. Quantitative comparisons
were made between various bactscatter material conditions when performing exit
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dosimetry. OSLD dose was 5.7% lower when no backscatter material was added
compared to full backscatter. Adding 0.5cm to 1.0cm water equivalent material reduced
the dose by 2%. The reduction in dose may vary due to the density of the tissue in the
primary beam path. These measurements demonstrated the importance of adding
appropriate backscatter material to improve the accuracy of the readings.
One made quantitative comparisons between OSL measurements and the depth dose
data from linear accelerator commissioning and those of a Markus ion chamber by
using a custom-designed heterogeneous phantom. Compared to the depth dose data,
OSL dose is 1% lower in the full backscatter condition, 2% with a 1cm backscatter and
there is a maximum of 6% reduction with no additional backscatter added. Compared
to the Markus ion chamber OSL readings show an insignificantly lower dose. Added
backscatter thickness, field size, energy, tissue or a tumour’s size and density along
the primary beam path-length, as well as the control/calibration dose will all affect OSL
response in in-vivo dosimetry.
The research work shows that OSL dosimetry can be an alternative dosimetry
technique for use in radiotherapy, especially for patient specific Quality Assurance
(QA) including skin dose measurement, IMRT plan checks, and linear accelerator QA.
In conclusion, OSL dosimetry can provide an alternative dosimetry technique for use in
radiotherapy if rigorous measurement protocols are established.
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Schematic of a Setup of a spherical phantom.
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Figure 9.9

Markus ion-chamber Experiment 1 results (2)
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Schematic of the setup for back scatter thickness influence measurements in a
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